Oncology & Cancer
AI-driven attention mechanisms aid in streamlining cancer pathology reporting
Artificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.
Mar 28, 2024
0
0
Artificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.
Mar 28, 2024
0
0
The U.S. Food and Drug Administration has approved Genentech's Alecensa (alectinib) as adjuvant treatment following tumor resection in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).
Apr 23, 2024
0
0